Schulz, Josefine
Michelet, Robin
Zeitlinger, Markus
Mikus, Gerd
Kloft, Charlotte
Funding for this research was provided by:
Freie Universität Berlin
Article History
Received: 1 June 2022
Accepted: 29 September 2022
First Online: 21 October 2022
Declarations
:
: C.K. reports grants from an industry consortium (AbbVie Deutschland GmbH and Co. KG, AstraZeneca Ltd., Boehringer Ingelheim Pharma GmbH & Co. KG, Grünenthal GmbH, F. Hoffmann-La Roche Ltd., Merck KGaA and Sanofi) for the PharMetrX PhD program, from the Federal Ministry of Education and Research and from European Commission for the Innovative Medicines Initiative-Joint Undertaking and within the Horizon2020 program, all outside the submitted work. The other authors declare that they have no conflict of interest.